Theophylline 24-Hour Extended Release Capsules and Tablets Shortage
Last Updated: December 30, 2024
Status: Current
Products Affected - Description
-
- Theo-24 extended release capsule, Endo Pharmaceuticals, 100 mg, bottle, 100 count, NDC 52244-0100-10
- Theophylline extended release tablet, Rhodes, 400 mg, bottle, 100 count, NDC 42858-0701-01
- Theophylline extended release tablet, Rhodes, 600 mg, bottle, 100 count, NDC 42858-0702-01 - discontinued
Reason for the Shortage
-
- Endo did not provide a reason for the shortage of Theo-24 100 mg capsules.
- Rhodes did not provide a reason for the shortage of theophylline 400 mg extended-release tablets. Rhodes discontinued the 600 mg extended-release tablets in May 2024 due to a business decision.
- Glenmark has theophylline 24-hour extended-release tablets available. The company is reviewing orders.
Available Products
-
- Theo-24 extended release capsule, Endo Pharmaceuticals, 200 mg, bottle, 100 count, NDC 52244-0200-10
- Theo-24 extended release capsule, Endo Pharmaceuticals, 300 mg, bottle, 100 count, NDC 52244-0300-10
- Theo-24 extended release capsule, Endo Pharmaceuticals, 400 mg, bottle, 100 count, NDC 52244-0400-10
- Theophylline extended release tablet, Glenmark, 400 mg, bottle, 100 count, NDC 68462-0380-01
- Theophylline extended release tablet, Glenmark, 600 mg, bottle, 100 count, NDC 68462-0356-01
Estimated Resupply Dates
-
- Endo has Theo-24 100 mg capsules on back order and the company cannot estimate a release date.
- Rhodes has theophylline 400 mg extended-release tablets on back order and the company cannot estimate a release date.
Updated
Updated December 30, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created August 22, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.